viewVectura Group PLC

Vectura clinches partnership with Australian university for postpartum haemorrhage prevention formula

The pair are looking to develop an inhaled formula while the current standard of care is injection

Vectura Group PLC - Vectura clinches partnership with Australian university for postpartum haemorrhage prevention formula

Vectura Group PLC (LON:VEC) has announced a partnership with Australia’s Monash University to develop inhaled oxytocin for prevention of postpartum haemorrhage (PPH) in childbirth.

The formulation would be delivered via a dry powder inhaler, while it currently can only be injected.

The UK-based pharma company said inhaling would be easier to use, act more quickly and could be stored safely without refrigeration.

As part of the agreement, Vectura will receive undisclosed revenues on a fee-for-service basis.

The World Health Organisation recommends that oxytocin is administered to every woman after birth to prevent PPH, which causes 60,000 deaths each year.

It mostly occurs in the poorest and hottest countries in the world, where injections are impracticable due to a lack of cold chain distribution and sterile environments, as well as trained clinicians to administer the drug.

“We see this as supportive of the CEO’s strategy to focus business development on the contract development and manufacturing organisation (CDMO) space to leverage Vectura’s inhalation formulation and device development expertise,” analysts at Peel Hunt commented.

Shares dipped 1% to 110.8p early on Monday.

Quick facts: Vectura Group PLC

Price: 110.8 GBX

Market: AIM
Market Cap: £660.47 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Red Rock Resources raises £1m to 'put rocket fuel into the engine'

  Red Rock Resources PLC's (LON:RRR) Andrew Bell talks to Proactive London about their £1m placing which will be used for their projects in Kenya, now that they have regained their license. Other projects in the Congo and Australia will also benefit from this placing and as Bell says,...

13 hours, 18 minutes ago

2 min read